Citigroup – AstraZeneca’s Vaccine Mistake Is a Shopping for Alternative, Citi Says

The Covid-19 vaccine research readout reported Monday by AstraZeneca wasn’t the success that was initially hailed by media within the firm’s residence base of Britain.

Whereas a fraction of these examined appeared to achieve 90% safety from the photographs, their doses resulted from what the corporate acknowledged was a mistake. The majority of volunteers who bought the supposed routine solely confirmed 62% safety. AstraZeneca then by some means pooled the combo of accident and design to reach at a claimed efficacy of 70%.

Scientists…